Scope Fluidics S.A. (SCP.WA)
Warsaw · PLN · Healthcare · Diagnostics & Research
PLN 156.40 (+3.30%) as of
Key statistics
- Market cap
- 495.52M
- EPS (TTM)
- -17.03
- Dividend yield
- 0.00%
- 52-week range
- 109.00 – 159.80
- Beta
- 0.02
- Revenue (TTM)
- -517k
- Profit margin
- 0.00%
- Analyst target
- PLN 223.90
- Volume
- 17.89k
About Scope Fluidics S.A.
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Warsaw, Poland
- Employees
- 175
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.